-
ANH-INTL FEATURE: Patancheru poisoning - the untold cost of the Western world’s cheap drugs
24 September 2014
Spotlight on toxic chemical disaster unfolding in southern India triggered by increasing demand for generic drugs in West
-
GSK has admitted it's guilty of fraud! Let’s boycott GSK products!
05 July 2012
All the information you need to send GSK a message via its bottom line
-
To drug or not to drug? That is the question!
05 April 2012
Using natural alternatives and sensible prevention, we say ‘not’
-
Bad week for Big Pharma!
16 April 2014
Three revelations reveal unacceptable deep corruption in pharma companies
-
Global pharmaceutical industry at a crossroads
08 July 2008
A German market research company has just issued a report which confirms that the pharma industry has its back against the wall. A leading expert says the industry "does not have a vision of the future". We say—be diligent, be astute and be careful, as a cornered rat can be dangerous.
-
Lamberts and Nature's Best bought by pharmaceutical company
25 August 2003
Merck KGaA, a major pharmaceutical company with the largest share in the UK vitamins and minerals market, has aquired Peter Black Direct Marketing which includes the two well-known businesses, Lamberts and Nature's Best.
-
The FSA fingers Pan Pharmaceutical products in the UK
20 June 2003
The second largest formulator of dietary supplements in the world feels the pain globally, after its license was suspended in Australia in late April. It is widely felt in industry circles that this suspension was overly harsh, particularly considering that the quality control problems that initiated the ban were primarily confined to a pharmaceutical product, rather than natural healthcare pro
-
IMAPping Big Pharma’s next moves
02 March 2012
Generics and ‘pharmerging markets’ the big targets as ideas run out
-
The FSA fingers Pan Pharmaceutical products in the UK (1)
10 October 2007
The second largest formulator of dietary supplements in the world feels the pain globally, after its license was suspended in Australia in late April. It is widely felt in industry circles that this suspension was overly harsh, particularly considering that the quality control problems that initiated the ban were primarily confined to a pharmaceutical product, rather than natural healthcare products which form the mainstay of the company's business. The ban has already resulted in the withdrawal of some 1500 healthcare products in Australia.
-
UK government blocks wider access to innovative cancer treatment
30 October 2013
Strange goings-on as the Department of Health announces 'cure for cancer'
What's Hot!
Become a Member!
Become an ANH Pathfinder today and help us co-create new health systems that respect nature as well as human rights and freedoms!
YouTube channel
SUBSCRIBE to our YouTube channel to become part of a growing community of Health Creators